Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Account Payables: 2018-2025

Historic Change in Account Payables for Bicycle Therapeutics (BCYC) over the last 7 years, with Sep 2025 value amounting to -$5.1 million.

  • Bicycle Therapeutics' Change in Account Payables fell 309.20% to -$5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.7 million, marking a year-over-year increase of 295.50%. This contributed to the annual value of $3.1 million for FY2024, which is 61.32% down from last year.
  • According to the latest figures from Q3 2025, Bicycle Therapeutics' Change in Account Payables is -$5.1 million, which was down 183.13% from $6.1 million recorded in Q2 2025.
  • Bicycle Therapeutics' Change in Account Payables' 5-year high stood at $10.7 million during Q4 2024, with a 5-year trough of -$5.9 million in Q1 2024.
  • Its 3-year average for Change in Account Payables is $646,091, with a median of -$431,000 in 2024.
  • Its Change in Account Payables has fluctuated over the past 5 years, first tumbled by 684.71% in 2023, then surged by 1,515.08% in 2025.
  • Quarterly analysis of 5 years shows Bicycle Therapeutics' Change in Account Payables stood at $926,000 in 2021, then plummeted by 355.94% to -$2.4 million in 2022, then soared by 275.82% to $4.2 million in 2023, then spiked by 156.49% to $10.7 million in 2024, then tumbled by 309.20% to -$5.1 million in 2025.
  • Its Change in Account Payables stands at -$5.1 million for Q3 2025, versus $6.1 million for Q2 2025 and -$5.0 million for Q1 2025.